Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosis with T cell receptor convergence CARLSBAD, Calif.

Speaking of information access, consider the challenges of organizing content faced by microarray database designers. First, the amount of information on microarrays can be enormous. Second, each ...

is exploring how to leverage the value of its extensive data to secure new revenue.The Ann Arbor-based health care IT and consulting services firm is also looking to add five employees for a total of ...

Thermo Fisher Scientific TMO recently received approval from the Food and Drug Administration (“FDA”) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be ...

Thermo Fisher Scientific Inc. TMO recently announced the receipt of the FDA premarket approval (PMA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify epidermal growth ...

CARLSBAD, Calif.--(BUSINESS WIRE)--In support of global initiatives to advance molecular profiling in oncology, Thermo Fisher Scientific today announced the latest recipients of the Oncomine Clinical ...

Chromobox (CBX) proteins were suggested to exert epigenetic regulatory and transcriptionally repressing effects on target genes and might play key roles in the carcinogenesis of a variety of ...